Symvivo Announcing Research Collaboration with Merck

“We are excited to be collaborating with Merck on this novel program,” said Lloyd Mackenzie, President and Chief Operating Officer at Symvivo. “This agreement builds on Symvivo’s efforts to develop the bacTRL™ platform across a range of diverse and important indications.”  

Canadian Media:

Chantal Allan
Sam Brown Inc. Healthcare Communications
T: 613-319-4384 (CAN)
T: 805-242-3080 (US)
E: chantalallan@sambrown.com

US Media:

Mike Beyer
Sam Brown Inc. Healthcare Communications
T: 312-961-2502
E: mikebeyer@sambrown.com